Arcturus Therapeutics Holdings, Inc. (ARCT)
15.19
-0.98
(-6.06%)
USD |
NASDAQ |
Aug 28, 16:00
15.18
-0.01
(-0.07%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Profit Margin (Quarterly) : -2.70K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.70K% |
| March 31, 2026 | -4.42K% |
| December 31, 2025 | -943.8% |
| September 30, 2025 | -95.02% |
| June 30, 2025 | -37.45% |
| March 31, 2025 | -55.25% |
| December 31, 2024 | -142.9% |
| September 30, 2024 | -17.78% |
| June 30, 2024 | -37.45% |
| March 31, 2024 | -82.27% |
| December 31, 2023 | -30.39% |
| September 30, 2023 | -37.40% |
| June 30, 2023 | -549.4% |
| March 31, 2023 | 63.66% |
| December 31, 2022 | 73.21% |
| September 30, 2022 | -263.8% |
| June 30, 2022 | -79.59% |
| March 31, 2022 | -975.8% |
| Date | Value |
|---|---|
| December 31, 2021 | -667.3% |
| September 30, 2021 | -2.22K% |
| June 30, 2021 | -2.73K% |
| March 31, 2021 | -2.65K% |
| December 31, 2020 | -1.39K% |
| September 30, 2020 | -900.3% |
| June 30, 2020 | -442.0% |
| March 31, 2020 | -369.5% |
| December 31, 2019 | -370.2% |
| September 30, 2019 | -224.0% |
| June 30, 2019 | -6.75% |
| March 31, 2019 | -158.3% |
| December 31, 2018 | -13.34% |
| September 30, 2018 | -124.2% |
| June 30, 2018 | -417.0% |
| March 31, 2018 | -277.6% |
| December 31, 2017 | -8.74% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Exelixis, Inc. | 33.73% |
| PTC Therapeutics, Inc. | 23.16% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -45.16% |
| Return on Assets | -35.00% |
| Return on Invested Capital | -40.29% |
| Gross Profit Margin (Quarterly) | 31.82% |
| Operating Margin (Quarterly) | -3.09K% |
| Return on Net Operating Assets | -262.8% |